Cognate B cell signaling via MHC class II:: Differential regulation of B cell antigen receptor and MHC class II/Ig-αβ signaling by CD22

被引:11
|
作者
Mills, DM
Stolpa, JC
Cambier, JC
机构
[1] Univ Colorado, Hlth Sci Ctr, Integrated Dept Immunol, Denver, CO 80206 USA
[2] Natl Jewish Med & Res Ctr, Denver, CO 80206 USA
来源
JOURNAL OF IMMUNOLOGY | 2004年 / 172卷 / 01期
关键词
D O I
10.4049/jimmunol.172.1.195
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Recent studies demonstrate that MHC class II molecules can signal via associated Ig-alphabeta dimers, signal transducers previously thought to function only in B cell Ag receptor (BCR) signaling. Surprisingly, the biologic outputs of MHC class II and BCR ligation (by thymus-dependent Ags) differ, e.g., MHC class II signaling leads to robust proliferation and extension of pseudopods. It seemed possible that these differences might be due, at least in part, to differential use of inhibitory coreceptors thought to modulate membrane Ig signals. In this study, we demonstrate that CD22, an inhibitory BCR coreceptor, neither associates with nor functions in MHC class II/Ig-alphabeta signaling. Interestingly, CD22 is actively excluded from cell surface MHC class II aggregates.
引用
收藏
页码:195 / 201
页数:7
相关论文
共 50 条
  • [31] DIFFERENTIAL REQUIREMENTS FOR CLASS II MHC ANTIGEN IN HUMAN T-CELL ACTIVATION
    GOEKEN, NE
    ECKERLE, MK
    LIOUBIN, PJ
    STAGGS, TS
    TRANSPLANTATION, 1984, 38 (06) : 714 - 719
  • [32] Ligation of MHC class II molecules differentially upregulates TNFβ gene expression in B cell lines of different MHC class II haplotypes
    Guo, WY
    Mourad, W
    Charron, D
    Al-Daccak, R
    HUMAN IMMUNOLOGY, 1999, 60 (04) : 312 - 322
  • [33] MHC Class II Transactivator (CIITA) Abnormalities Are Frequent in B-cell Lineage Lymphomas and Are Associated With Loss of MHC Class II (MHCII)
    Jelloul, Fatima Zahra
    Pichardo, Janine D.
    Khattar, Pallavi
    Ananthamurthy, Anuradha
    Rao, Mamta
    Areeyqur, Ruth
    Jungbluth, Achim
    Wang, Lu
    Zhang, Yanming
    Dogan, Ahmet
    MODERN PATHOLOGY, 2018, 31 : 525 - 525
  • [34] A ROLE FOR MHC CLASS-II ANTIGENS IN B-CELL ACTIVATION
    MOONEY, N
    GRILLOTCOURVALIN, C
    HIVROZ, C
    CHARRON, D
    JOURNAL OF AUTOIMMUNITY, 1989, 2 : 215 - 223
  • [35] THE BIOCHEMISTRY AND CELL BIOLOGY OF MHC CLASS-II ANTIGEN PRESENTATION
    GERMAIN, RN
    CASTELLINO, F
    RINKER, AG
    SADEGHNASSERI, S
    ROMAGNOLI, P
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 286 - 286
  • [36] MHC Class II Transactivator (CIITA) Abnormalities Are Frequent in B-cell Lineage Lymphomas and Are Associated With Loss of MHC Class II (MHCII) Expression
    Jelloul, Fatima Zahra
    Pichardo, Janine D.
    Khattar, Pallavi
    Ananthamurthy, Anuradha
    Rao, Mamta
    Areeyqur, Ruth
    Jungbluth, Achim
    Wang, Lu
    Zhang, Yanming
    Dogan, Ahmet
    LABORATORY INVESTIGATION, 2018, 98 : 525 - 525
  • [37] Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling
    Jin, L
    McLean, PA
    Neel, BG
    Wortis, HH
    JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (09): : 1199 - 1205
  • [38] ASSOCIATION OF CD22 WITH THE B-CELL ANTIGEN RECEPTOR
    PEAKER, CJG
    NEUBERGER, MS
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (06) : 1358 - 1363
  • [39] The MHC Class II Cofactor HLA-DM Interacts with Ig in B Cells
    Macmillan, Henriette
    Strohman, Michael J.
    Ayyangar, Sashi
    Jiang, Wei
    Rajasekaran, Narendiran
    Spura, Armin
    Hessell, Ann J.
    Madec, Anne-Marie
    Mellins, Elizabeth D.
    JOURNAL OF IMMUNOLOGY, 2014, 193 (06): : 2641 - 2650
  • [40] Regulation of T cell autoreactivity to MHC class II by controlling CD80 (B7-1) expression on B cells
    Hasegawa, A
    Ueno, Y
    Yamashita, M
    Nakayama, T
    Tada, T
    INTERNATIONAL IMMUNOLOGY, 1998, 10 (02) : 147 - 158